Related references
Note: Only part of the references are listed.Inhibition of amyloid Ab aggregation by high pressures or specific D-enantiomeric peptides
Italo A. Cavini et al.
CHEMICAL COMMUNICATIONS (2018)
Surprisingly high stability of the Aβ oligomer eliminating all-D-enantiomeric peptide D3 in media simulating the route of orally administered drugs
Anne Elfgen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease
Janine Kutzsche et al.
MOLECULES (2017)
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease
Min Jeong Wang et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
Thomas van Groen et al.
SCIENTIFIC REPORTS (2017)
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay
Kateryna Kravchenko et al.
BIOLOGICAL CHEMISTRY (2017)
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body fluids
Yvonne Herrmann et al.
CLINICAL BIOCHEMISTRY (2017)
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies
Yvonne Herrmann et al.
CLINICA CHIMICA ACTA (2017)
Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers
Leonie H. E. Leithold et al.
PHARMACEUTICAL RESEARCH (2016)
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy
Jing Liu et al.
DRUGS & AGING (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Biofunctionalized Silica Nanoparticles: Standards in Amyloid-beta Oligomer-Based Diagnosis of Alzheimer's Disease
Maren Huelsemann et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Katja Kuehbach et al.
FRONTIERS IN NEUROSCIENCE (2016)
Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains
Christopher Janus et al.
NEUROBIOLOGY OF AGING (2015)
Hybridization of an Aβ-specific antibody fragment with aminopyrazole-based β-sheet ligands displays striking enhancement of target affinity
Marco Hellmert et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
A review on Alzheimer's disease pathophysiology and its management: an update
Anil Kumar et al.
PHARMACOLOGICAL REPORTS (2015)
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease
Sergio T. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers
Oleksandr Brener et al.
SCIENTIFIC REPORTS (2015)
Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer's Disease
Nan Jiang et al.
PLOS ONE (2015)
A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
Mary J. Savage et al.
JOURNAL OF NEUROSCIENCE (2014)
Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult
William I. Rosenblum
NEUROBIOLOGY OF AGING (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Impairment of nesting behaviour in 3xTg-AD mice
Virginia Torres-Lista et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Treatment with D3 Removes Amyloid Deposits, Reduces Inflammation, and Improves Cognition in Aged AβPP/PS1 Double Transgenic Mice
Thomas van Groen et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
Lei Wang-Dietrich et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
A comparison of InVivoStat with other statistical software packages for analysis of data generated from animal experiments
Robin A. Clark et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease
Willem Kamphuis et al.
PLOS ONE (2012)
Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
Wei Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease
Sergio T. Ferreira et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Oral Treatment with the D-Enantiomeric Peptide D3 Improves the Pathology and Behavior of Alzheimer's Disease Transgenic Mice
Susanne Aileen Funke et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Bapineuzumab
Geoffrey A. Kerchner et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1ΔE9-deleted transgenic mice model of β-amyloidosis
Arturas Volianskis et al.
NEUROBIOLOGY OF AGING (2010)
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Roland Jakob-Roetne et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease
Mohammed Filali et al.
BRAIN RESEARCH (2009)
In vitro and in vivo Staining Characteristics of Small, Fluorescent, Aβ42-Binding D-Enantiomeric Peptides in Transgenic AD Mouse Models
Thomas van Groen et al.
CHEMMEDCHEM (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Reduction of Alzheimer's Disease Amyloid Plaque Load in Transgenic Mice by D3, a D-Enantiomeric Peptide Identified by Mirror Image Phage Display
Thomas van Groen et al.
CHEMMEDCHEM (2008)
The current state of serum biomarkers of hepatotoxicity
Josef Ozer et al.
TOXICOLOGY (2008)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
Digging and marble burying in mice: simple methods for in vivo identification of biological impacts
Robert M. J. Deacon
NATURE PROTOCOLS (2006)
Assessing nest building in mice
Robert M. J. Deacon
NATURE PROTOCOLS (2006)
Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease:: Relationships to β-amyloid deposition and neurotransmitter abnormalities
A Savonenko et al.
NEUROBIOLOGY OF DISEASE (2005)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Share Paper
